Target Gene/Pathway Pathway / Gene
Search results
Showing 1 to 10 of 27 entries
| No. | KEGG GENES | KEGG PATHWAY | KEGG DRUG | DrugBank | 指定難病告示番号 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
IL17RA
💬1. IL17RA
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Alcoholic liver disease | Brodalumab
Brodalumab
💬1. IL17RA
| Brodalumab | 2件: 37 37, 51 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 |
HPRT1
💬2. HPRT1
| 4件: Purine metabolism Purine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism | Tioguanine
Tioguanine
💬2. HPRT1
| Tioguanine | 2件: 13 13, 37 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 |
IL1R1
💬3. IL1R1
| 13件: MAPK signaling pathway MAPK signaling pathway, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Hematopoietic cell lineage, Th17 cell differentiation, Inflammatory mediator regulation of TRP channels, Pathogenic Escherichia coli infection, Shigellosis, Amoebiasis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Fluid shear stress and atherosclerosis 13件: MAPK signaling pathway, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, O ... | Anakinra
Anakinra
💬3. IL1R1
| Anakinra | 18件: 2 2, 13, 15, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬3. IL1R1
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 |
IL12A
💬4. IL12A
| 25件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, C-type lectin receptor signaling pathway, JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Alcoholic liver disease, Type I diabetes mellitus, Pertussis, Legionellosis, Leishmaniasis, Chagas disease, African trypanosomiasis, Malaria, Toxoplasmosis, Amoebiasis, Tuberculosis, Measles, Influenza A, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Pathways in cancer, Inflammatory bowel disease, Allograft rejection, Lipid and atherosclerosis 25件: Cytokine-cytokine receptor interaction, Toll-like receptor signaling pathway, RIG-I-like recept ... | Ustekinumab
Ustekinumab
💬4. IL12A
| Ustekinumab | 16件: 37 37, 40, 41, 46, 49, 50, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬4. IL12A
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 |
IL12B
💬5. IL12B
| 25件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, C-type lectin receptor signaling pathway, JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Alcoholic liver disease, Type I diabetes mellitus, Pertussis, Legionellosis, Leishmaniasis, Chagas disease, African trypanosomiasis, Toxoplasmosis, Amoebiasis, Tuberculosis, Measles, Influenza A, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Pathways in cancer, Proteoglycans in cancer, Inflammatory bowel disease, Allograft rejection, Lipid and atherosclerosis 25件: Cytokine-cytokine receptor interaction, Toll-like receptor signaling pathway, RIG-I-like recept ... | Ustekinumab
Ustekinumab
💬5. IL12B
| Ustekinumab | 16件: 37 37, 40, 41, 46, 49, 50, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬5. IL12B
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 |
IL17A
💬6. IL17A
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Th17 cell differentiation, Alcoholic liver disease, Inflammatory bowel disease, Rheumatoid arthritis 6件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Th17 cell differentiation, Alco ... | Secukinumab
Secukinumab
💬6. IL17A
| Secukinumab | 8件: 13 13, 37, 41, 46, 107, 160, 269, 271 💬6. IL17A
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 |
IL17A
💬7. IL17A
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Th17 cell differentiation, Alcoholic liver disease, Inflammatory bowel disease, Rheumatoid arthritis 6件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Th17 cell differentiation, Alco ... | Ixekizumab
Ixekizumab
💬7. IL17A
| Ixekizumab | 8件: 36 36, 37, 46, 107, 160, 162, 269, 271 💬7. IL17A
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 |
ITGAL
💬8. ITGAL
| 12件: Rap1 signaling pathway Rap1 signaling pathway, Cell adhesion molecules, Neutrophil extracellular trap formation, Natural killer cell mediated cytotoxicity, Leukocyte transendothelial migration, Regulation of actin cytoskeleton, Malaria, Staphylococcus aureus infection, Human T-cell leukemia virus 1 infection, Epstein-Barr virus infection, Rheumatoid arthritis, Viral myocarditis 12件: Rap1 signaling pathway, Cell adhesion molecules, Neutrophil extracellular trap formation, Natur ... | Efalizumab
Efalizumab
💬8. ITGAL
| Efalizumab | 9件: 11 11, 13, 37, 46, 49, 53, 61, 95, 96 💬8. ITGAL
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 |
MTNR1A
💬9. MTNR1A
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Circadian entrainment | Melatonin
Melatonin
💬9. MTNR1A
| Melatonin | 12件: 6 6, 8, 13, 37, 46, 49, 72, 78, 90, 97, 145, 202 💬9. MTNR1A
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 |
MTNR1B
💬10. MTNR1B
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Circadian entrainment | Melatonin
Melatonin
💬10. MTNR1B
| Melatonin | 12件: 6 6, 8, 13, 37, 46, 49, 72, 78, 90, 97, 145, 202 💬10. MTNR1B
|